Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes - PubMed (original) (raw)

Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes

P Ray et al. J Clin Invest. 1997.

Abstract

Standard overexpression transgenic approaches are limited in their ability to model waxing and waning diseases and frequently superimpose development-dependent and -independent phenotypic manifestations. We used the clara cell 10-kD protein (CC10) promoter and the reverse tetracycline transactivator (rtTA) to create a lung-specific, externally regulatable, overexpression transgenic system and used this system to express human interleukin 11 (IL-11) in respiratory structures. Gene induction could be achieved in utero, in neonates and in adult animals. Moreover, gene expression could be turned off by removal of the inducing stimulus. When gene activation was initiated in utero and continued into adulthood, subepithelial airway fibrosis, peribronchiolar mononuclear nodules, and alveolar enlargement (emphysema) were noted. Induction in the mature lung caused airway remodeling and peribronchiolar nodules, but alveolar enlargement was not appreciated. In contrast, induction in utero and during the first 14 d of life caused alveolar enlargement without airway remodeling or peribronchiolar nodules. Thus, IL-11 overexpression causes abnormalities that are dependent (large alveoli) and independent (airway remodeling, peribronchiolar nodules) of lung growth and development, and the CC10-rtTA system can be used to differentiate among these effector functions. The CC10-rtTA transgenic system can be used to model waxing and waning, childhood and growth and development-related biologic processes with enhanced fidelity.

PubMed Disclaimer

Similar articles

• Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice.
  Zhu Z, Ma B, Homer RJ, Zheng T, Elias JA. Zhu Z, et al. J Biol Chem. 2001 Jul 6;276(27):25222-9. doi: 10.1074/jbc.M101512200. Epub 2001 Apr 30. J Biol Chem. 2001. PMID: 11331286
• Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness.
  Hjoberg J, Shore S, Kobzik L, Okinaga S, Hallock A, Vallone J, Subramaniam V, De Sanctis GT, Elias JA, Drazen JM, Silverman ES. Hjoberg J, et al. J Appl Physiol (1985). 2004 Jul;97(1):249-59. doi: 10.1152/japplphysiol.01389.2003. Epub 2004 Mar 12. J Appl Physiol (1985). 2004. PMID: 15020581
• Expression of the reverse tetracycline-transactivator gene causes emphysema-like changes in mice.
  Sisson TH, Hansen JM, Shah M, Hanson KE, Du M, Ling T, Simon RH, Christensen PJ. Sisson TH, et al. Am J Respir Cell Mol Biol. 2006 May;34(5):552-60. doi: 10.1165/rcmb.2005-0378OC. Epub 2006 Jan 13. Am J Respir Cell Mol Biol. 2006. PMID: 16415250 Free PMC article.
• Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung.
  Kuhn C 3rd, Homer RJ, Zhu Z, Ward N, Flavell RA, Geba GP, Elias JA. Kuhn C 3rd, et al. Am J Respir Cell Mol Biol. 2000 Mar;22(3):289-95. doi: 10.1165/ajrcmb.22.3.3690. Am J Respir Cell Mol Biol. 2000. PMID: 10696065
• IL-11: insights in asthma from overexpression transgenic modeling.
  Zheng T, Zhu Z, Wang J, Homer RJ, Elias JA. Zheng T, et al. J Allergy Clin Immunol. 2001 Oct;108(4):489-96. doi: 10.1067/mai.2001.118510. J Allergy Clin Immunol. 2001. PMID: 11590369 Review.

Cited by

• Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway.
  Ng B, Cook SA, Schafer S. Ng B, et al. Exp Mol Med. 2020 Dec;52(12):1871-1878. doi: 10.1038/s12276-020-00531-5. Epub 2020 Dec 1. Exp Mol Med. 2020. PMID: 33262481 Free PMC article. Review.
• Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells.
  Strikoudis A, Cieślak A, Loffredo L, Chen YW, Patel N, Saqi A, Lederer DJ, Snoeck HW. Strikoudis A, et al. Cell Rep. 2019 Jun 18;27(12):3709-3723.e5. doi: 10.1016/j.celrep.2019.05.077. Cell Rep. 2019. PMID: 31216486 Free PMC article.
• Animal Models, Learning Lessons to Prevent and Treat Neonatal Chronic Lung Disease.
  Jobe AH. Jobe AH. Front Med (Lausanne). 2015 Aug 7;2:49. doi: 10.3389/fmed.2015.00049. eCollection 2015. Front Med (Lausanne). 2015. PMID: 26301222 Free PMC article. Review.
• Combined exposure to cigarette smoke and nontypeable Haemophilus influenzae drives development of a COPD phenotype in mice.
  Ganesan S, Comstock AT, Kinker B, Mancuso P, Beck JM, Sajjan US. Ganesan S, et al. Respir Res. 2014 Feb 4;15(1):11. doi: 10.1186/1465-9921-15-11. Respir Res. 2014. PMID: 24495712 Free PMC article.
• IL-18 induces emphysema and airway and vascular remodeling via IFN-γ, IL-17A, and IL-13.
  Kang MJ, Choi JM, Kim BH, Lee CM, Cho WK, Choe G, Kim DH, Lee CG, Elias JA. Kang MJ, et al. Am J Respir Crit Care Med. 2012 Jun 1;185(11):1205-17. doi: 10.1164/rccm.201108-1545OC. Epub 2012 Mar 1. Am J Respir Crit Care Med. 2012. PMID: 22383501 Free PMC article.

References

1. 1. Dev Biol. 1996 May 1;175(2):227-38 - PubMed
2. 1. J Immunol. 1997 Sep 1;159(5):2161-8 - PubMed
3. 1. Cell. 1996 Jun 14;85(6):863-73 - PubMed
4. 1. Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7387-91 - PubMed
5. 1. J Immunol. 1996 Aug 15;157(4):1705-10 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • American Society for Clinical Investigation
  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations

• Miscellaneous

  • NCI CPTAC Assay Portal